Upon completion of the video presentation, to finish the activity and claim your credit, please click here.

This activity is supported by an independent educational grant from Merck Sharp & Dohme Corp.

Advances in the Management of Patients with Urothelial Carcinomas of the Bladder

The University of Texas MD Anderson Cancer Center

Amishi Shah, MD
The University of Texas MD Anderson Cancer Center

Get an update on the state of chemotherapy and immunotherapy for the treatment of urothelial carcinomas of the bladder. Learn how these therapies combat the various types of urothelial carcinomas and how to identify their most common side effects, including immune-related adverse effects from immunotherapy.


Download Podcast

   To claim credit for podcast click here

Download Transcript


Download Slides


Download Slides & Transcripts

   To claim credit for the slides & transcript click here

These CME/CE/CPE accredited activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.